Company Filing History:
Years Active: 2010-2011
Title: The Innovations of Ronghua Li
Introduction
Ronghua Li is a notable inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of kinase inhibitors. With a total of 2 patents, his work focuses on addressing various protein kinase-mediated diseases.
Latest Patents
Ronghua Li's latest patents include innovative compounds aimed at treating chronic and acute conditions. One of his patents is titled "Substituted pyrimidine kinase inhibitors," which is directed to substituted pyrimidine compounds and their use in treating diseases associated with protein kinases. Another significant patent is "Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders." This invention provides compounds that are effective in treating or ameliorating kinase-mediated disorders, including those related to angiogenesis and hyperproliferation.
Career Highlights
Ronghua Li is currently employed at Janssen Pharmaceutica NV, where he continues to advance his research and development efforts. His work at this leading pharmaceutical company allows him to contribute to innovative solutions in healthcare.
Collaborations
Throughout his career, Ronghua Li has collaborated with esteemed colleagues, including Shenlin Huang and Peter J Connolly. These collaborations have further enhanced the impact of his research and inventions.
Conclusion
Ronghua Li's contributions to the field of pharmaceutical sciences through his patents and collaborations highlight his dedication to innovation. His work in developing kinase inhibitors is paving the way for new treatments for complex diseases.